Why Should we Worry and How to Treat LP(a)

Saturday, February 25, 2023

7:32 PM – 7:40 PM ET

Speaker(s)

Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI

Professor of Medicine (Cardiology), and Population Health Science and Policy; Director of Interventional Cardiovascular Research and Clinical Trials
Icahn School of Medicine at Mount Sinai
New York, New York, United States

Disclosure information not submitted.

Disclosure(s):

Pieter C. Smits, PhD, FESC: Abbott Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Grants/Research Support Recipient (Ongoing); Abiomed: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated); Arena Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); AstraZeneca Pharmaceuticals: Consulting Fees (e.g., advisory boards) (Terminated); Daiichi Sankyo, Inc.: Grants/Research Support Recipient (Terminated); MicroPort Medical: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing), Grant Recipient (Ongoing), Scientific Research Study Investigator (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); SMT: Contracted Research (Principal Investigators must provide information, even if received by the institution) (Ongoing); Terumo Corporation: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)